Navigation Links
The CNIO welcomes the new academic year with a spotlight on cancer genetics

The Distinguished Seminars series, the most prestigious scientific conferences at the Spanish National Cancer Research Centre (CNIO), welcome the new academic year with a double bill focusing on cancer genetics next Thursday and Friday. The conference schedule will last until next June, with over 30 scientific talks of international excellence.

The Nobel laureate Robert Huber, from the Max Planck Institute of Biochemistry (Germany), will give a talk next Thursday, September 6th, on cellular mechanisms used to degrade faulty or unnecessary proteins, processes whose failure can lead to serious diseases. The lecture, titled Intracellular proteolysis, structures, mechanisms and drug design, will be held at the CNIO Auditorium at 12:00.

On Friday 7th, Peter Campbell, researcher at The Wellcome Trust Sanger Institute (UK) and co-director of the Cancer Genome Project in the UK, will explain what scientists hope to learn from the genomic analysis of 50 different tumour types, and its role in future cancer treatments. The talk is titled Interrogating the architecture of cancer genomes and will also be held at the CNIO Auditorium at 12:00 noon.

A talk by Kári Stefánsson is also scheduled for the first half of September. Stefánsson, a neurologist who will give a lecture on Friday 14th titled The genetics of common traits, works for Decode Genetics (Iceland). A company which thanks to an especial agreement has spent the last years studying the medical and genetic data of Icelanders.

Their latest research, published last month, describes the relationship between paternal age and children's susceptibility to some genetic diseases. On its website, Decode Genetics boasts to have discovered "key genetic risk factors for dozens of common diseases, from cardiovascular diseases to cancer."

This ambitious programme brings world leaders in scientific research to Spain every year. The full programme of the Distinguished Seminars series and other conferences organized by the CNIO is available at, Scientific Events section.

Contact: Nuria Noriega
Centro Nacional de Investigaciones Oncologicas (CNIO)

Related biology news :

1. EMBO welcomes 55 leading life scientists as members
2. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
3. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
4. 7 pharmaceutical companies join academic researchers to speed TB drug discovery
5. The academic jungle: Ecosystem model reveals why women are driven out of science
6. Athletic field paint steals spotlight from the grass it covers
7. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
8. Embryonic development protein active in cancer growth
9. BRG1 mutations confer resistance to hormones in lung cancer
10. Genetic variation in East Asians found to explain resistance to cancer drugs
11. Beyond the microscope: Identifying specific cancers using molecular analysis
Post Your Comments:
(Date:11/9/2015)... , Nov. 09, 2015 ... addition of the "Global Law Enforcement ... offering. --> ) has ... Law Enforcement Biometrics Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... 2015 Today, LifeBEAM , a ... 2XU, a global leader in technical performance sports ... with advanced bio-sensing technology. The hat will allow ... key biometrics to improve overall training performance. As ... will bring together the most advanced technology, extensive ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... England , November 26, 2015 ... innovative medical device company specializing in imaging technologies, announced today ... European Commission as part of the Horizon 2020 European Union ... carry out a large-scale clinical trial in breast cancer. ... (Logo: , --> --> ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
Breaking Biology Technology: